Immune checkpoint inhibitors (ICI) have become a cornerstone in medical oncology,
continually evolving therapeutic strategies and applications. These monoclonal antibodies …

Hyperthyroidism and hypothyroidism are common diseases resulting from thyroid
dysfunction, and are simple to diagnose and treat. The traditional treatment for …

One of the major causes of immunotherapy resistance is the loss of major histocompatibility
complex class I (MHC‐I) molecules in tumor cells or the downregulation of the class I …

The immune system is a complex and interconnected system that has evolved to protect its
host from foreign pathogens. CD8+ T cells are a type of immune cell that can be directly …

Introduction Hypophysitis is reported in 8.5%–14% of patients receiving combination
immune checkpoint inhibition (cICI) but can be a diagnostic challenge. This study aimed to …

Background: Immune-checkpoint inhibitors (ICIs) are effective against various cancers;
however, immune-related adverse events (irAEs) have been reported and the timing and …

Cancer is a worldwide disease that ranks as the second-largest cause of death after
cardiovascular disease. In 2019, the estimated number of cancer deaths was around 10 …

Through improving the immune system's ability to recognize and combat tumor cells as well
as its receptivity to changes in the tumor microenvironment, immunotherapy has emerged as …

Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted
Therapy for Cancers: A Single-Center Study from Thailand - PMC Back to Top Skip to main …

Objective We aimed to characterize cancer patients who developed isolated
adrenocorticotrophic hormone (ACTH) deficiency (IAD) after treatment with checkpoint …